A flexible pharmaceutical company with great potential for European manufacturing of contrast agents and APIs.
As one of the world’s major suppliers and contract manufacturers (CMO) of generic contrast agents, Sanochemia already offers some of the most established CT/XRT and MRI products on the market.
The current focus is on the development, production, and distribution of drugs, particularly for radiology, neurology, and oncology. Especially in the area of contract manufacturing of specialties, the company plans to offer itself to large pharmaceutical companies as a European ‘second source’ for the production of specialty active ingredients. On-site partnerships with local B2B partners ensure adequate market access in over 35 countries, and international expansion is to be further intensified. A solid basis for future developments is provided by many years of experience as a manufacturer of contrast agents for diagnostic imaging and active ingredients.
Mühldorfer Nutrition is known as a reliable partner for the German-speaking specialized trade. The company offers private label and contract manufacturing in the areas of specialty feeds, petfood, and pharmaceutical and care products for animals.
Constant availability and first-class quality with an excellent price-performance ratio characterize Mühldorfer Nutrition AG. With a wide range of services and high clout, the company convinces with a variety of possibilities.
As a reliable intermediary between industry, trade and end customers, the Group provides an innovative and broad product portfolio for the European market – from its own production in the field of horse feed and nutrition supplements to “white label” contract production and almost all important retail brands. The in-house product portfolio of more than 4,000 products and the services offered are constantly being expanded. Modern production facilities, experience in brand development paired with sales competence as well as complementary organizational structures make comprehensive potential evident.
With an all-in concept, innovative products can be manufactured as part of contract manufacturing or entire ranges can be taken to market maturity. Private label customers benefit from a comprehensive range of animal feed, specialties and care products – for horses, dogs, cats and rodents. Downstream logistics offerings allow maximum flexibility. At the same time, new cooperative ventures with renowned innovative manufacturers in the industry are being driven forward.
BDI-Bio Energy is an Austrian full-service provider of innovative greentech solution systems.
Since it was founded in 1996, BDI-BioEnergy International has been developing resource-saving technologies for upgrading residual and waste products from industry and commerce. The company offers customers support along the entire value chain. At the same time, BDI-BioEnergy International sets new standards in terms of innovative strength, technological lead, product quality and cost-effectiveness.
The company stands out with its many years of expertise in international plant engineering and comprehensive know-how in planning industrial plants. BDI-BioEnergy International’s expertise is evidenced by over 70 projects around the world, while its innovative strength is underpinned by more than 320 registered patents. As a specialist manufacturer of plants for special requirements, the company sets technological standards in the refinement of residual and waste materials with its specially developed multi-feedstock process.
The customized biodiesel industrial plants produce biodiesel from a wide range of raw materials that meets the world’s strictest standards. The spectrum covers all services that are decisive for the customer: from the development of new processes, scale-up, front-end, regulatory, basic and detail engineering to the construction of turnkey plants. The commissioning and training of plant personnel is subsequently supplemented by qualified customer service.
Highly effective ingredients for the life science industry, developed using state-of-the-art technologies.
BioLife Science, based in Hartberg/Austria, specializes in the production of high-quality algae materials (or valuable substances) for the life science sector and is number one in the production of natural astaxanthin in Central Europe.
With the self-developed, closed algae cultivation process, the company ensures year-round product availability of natural astaxanthin of the highest quality, and research and development work is carried out in its own astaxanthin competence center in compliance with the highest standards. The company has certifications such as COSMOS, FSSC 22000, Halal, ISO 9001, Kosher or Natrue Approval.
Whether standardized or tailor-made, BDI-BioLife Science offers its customers a variety of innovative frame formulations, unique prototypes through to bulk goods and finished B2C products. At the same time, customers are supported in all phases of product development tailored to their individual needs: from the initial idea to prototype testing, production and packaging design.
Graz-based EOSS Industries, Kanzler Verfahrenstechnik and the Rieckermann Group announce their strategic cooperation and the acquisition of BDI-BioEnergy International GmbH.
Using AI from Styria to convert CO2 into biofuel, break down pet bottles into chemicals or assess the danger of viruses. With the help of Innophore’s platform, biological reactions can be predicted in the middle of Graz.
New wet food saves meat resources by adding “vegetarian meat”. Mühldorfer Nutrition AG’s latest product development thus combines species-appropriate animal nutrition and sustainability.
Our portfolio company excels with sustained growth and orders worth over €900 million processed via ACL systems in 2022.
